Thursday 29 December 2022

12 Power Finance Corp

The stock came up on the HDY screen and I will hold it for longer and hope the company pays dividends.

***

Buy date: 29-Dec-2022

Qty: 581 Price: ₹137 EPS₹53.55

Div. Yield is 9.12%

Dividends are consistent since 2007 except in 2019.

***

Buy date: 11-May-2022

Qty: 91 Price: ₹109.85 EPS₹52.01

***

Buy date: 06-Jan-2022

Qty: 81 Price: ₹122.95 EPS₹49.41

The reason for owning a dividend-paying company is dividends can be used as cash flow and very few people hold stocks forever, I want to be in those very few. There will be few losses because of the company going bankrupt since I am investing only 1% in single stock the losses will be minimal. Basically treating investment in companies as buying a house and expecting them to pay rent every year. The best investment I have made so far is my house which pays rent every month so trying to convert investments into rent-paying assets.

Monday 26 December 2022

11 GTPL Hathway

The stock came up on the HDY screen and I will hold it for longer and hope the company pays dividends.

***

Buy date: 26-Dec-2022

Qty: 805 Price: ₹124.2 EPS₹17.54

Dividends are consistent for the last 5 years

Friday 23 December 2022

10 Monte Carlo Fashions

 The stock came up on the HDY screen and I will hold it for longer and hope the company pays dividends.

***

Buy date: 23-Dec-2022

Qty: 156 Price: ₹636.4 EPS₹56.25

8 GHCL

 The stock came up on the HDY screen and I will hold it for longer and hope the company pays dividends.

***

Buy date: 23-Dec-2022

Qty: 200 Price: ₹497.05 EPS₹113.15

7 Visaka Industries

Reasons for buying:

Buy PE was reasonable at 9.27 and above 10 years PE median of 8.9.

Earnings have increased 3 times from 2012.

Return on equity is good at 19.55%.

The market cap of the company is ₹1,096.23cr.

The debt of the company is ₹115.49cr with ₹116.81cr in cash.

Buy date: 6-Oct-2021

Qty: 15 Buy Price: ₹657 Buy EPS: 70.87 Buy PE: 9.27

The earnings have increased by 1.28%. I will stop buying when EPS falls to 32.85.

Buy date: 18-Nov-2021

Qty: 16 Buy Price: ₹591.00 Buy EPS: 71.78 Buy PE: 8.23

The stock came up on the HDY screen and I will hold it for longer and hope the company pays dividends.

***

Buy date: 23-Dec-2022

Qty: 165 Price: ₹424.8 EPS₹58.03

Visaka Industries Ltd is a manufacturer of Roofing sheets and Cement sheets. It also manufactures Fiber sheets, Industrial sheets, FIber cement, corrugated sheets, Fiber cement sheets, and Roofing sheets. The company's activities are organized into two operating segments namely. Building Products and Textile Synthetic Yarn. Building products division products asbestos sheets, accessories used mostly as roofing material and non-asbestos flat sheets and sandwich panels used as interiors. Its synthetic yarn division manufactures yarn out of blends of polyester, viscose, and other materials which go into the weaving of the fabric. It generates maximum revenues from the building products segment. Geographically it derives a majority of revenues from India.

6 Sanofi India Update

Reasons for buying:

Market Cap: ₹13,602 Cr (Bluechip stock)

Debt to Equity: 0.05

Return on Equity 5Y Avg: 23.83%

EPS - 5Y Growth: 29.46%

Price-earnings to growth (5Y): 0.47

5Y RoE Consistency - Sustained without losing 20% in any year

Buy date: 4-Apr-2022

Qty: 1 Buy Price: ₹7,400 Buy EPS: 410.06

Buy date: 10-May-2022

Qty: 1 Buy Price: ₹6,660 Buy EPS: 450.22

Buy date: 23-Sep-2022

Qty: 1 Buy Price: ₹5,908.95 Buy EPS: 425.08

The yield is 3% and paid dividend continues with good fundamentals so added more.

Buy date: 23-Dec-2022

Qty: 12 Price: ₹5833.85 EPS₹251.88

Will continue to add when a stock falls 10% as long as the ratios remain the same. The stock would take a long time to pay, it lost 20% since I bought it in April.

Sanofi India is a drug manufacturing company that focuses on a range of therapeutic areas, including Diabetes, Cardiology, Consumer Healthcare, Hospitals, Central Nervous systems, and Anti-Histamines. The company's diabetes presence includes oral anti-diabetic products and insulin. The consumer healthcare area also maintains a nutraceutical portfolio. The company's export markets include Germany, the U.K., Australia, and Russia. The company utilizes strategic partnerships as a component of its growth strategy.

5 Sutlej Textiles and Industries Update

The stock came up on the HDY screen and I will hold it for longer and hope the company pays dividends.

***

Buy date: 23-Dec-2022

Qty: 1690 Price: ₹59.15 EPS₹10.06

The stock came up on the HDY screen and will hopefully sell in a short period of time.

***

Buy date: 14-Nov-2022

Qty: 163 Price: ₹61 EPS₹10.06

Sell date: 30-Nov-2022

Qty: 163 Price: ₹62.3 EPS₹10.06

Profit: ₹211.9

***

Will sell if it is not present on the screen

Wednesday 14 December 2022

4 MOIL Update

The stock came up on the HDY screen and I will hold it for longer and hope the company pays dividends.

Buy date: 05-09-2022

Qty: 58 Price: ₹169.55 EPS: 18.08

Buy date: 15-12-2022

Qty: 549 Price: ₹164 EPS: 16.87

Dividend paid: 174

Tuesday 13 December 2022

3 Cosmo First Update

The stock came up on the HDY screen and I will hold it for longer and hope the company pays dividends.

Buy date: 13-12-2022

Qty: 130 Price: 767 EPS: 146.6

The stock came up on the HDY screen and will hopefully sell in a short period of time.

***

Buy date: 15-Nov-2022

Qty: 14 Price: ₹690 EPS₹146.6

Sold Date: 30-Nov-2022

Qty: 14 Price: ₹796.95 EPS₹146.6

Profit: 1,497.3

***

Will sell if it is not present on the screen

Monday 12 December 2022

2 Tamilnadu Petroproducts Update

The stock came up on the HDY screen, I had bought the stock previously. This time I will hold it for a long time and hope it pays dividends.

Buy date: 13-Dec-2022 

Qty: 964 Price: 93.4 EPS: 14.44

Buy date: 11-Oct-2022

Qty: 101 Price: ₹98.55 EPS₹16.5

***

Buy date: 28-Sep-2022

Qty: 103 Price: ₹96.8 Buy EPS: ₹16.5

Sell date: 06-Oct-2022

Qty:103  Price: ₹101 Buy Eps: ₹16.5

Profit: 432.6

***

Buy date: 03-Oct-2022

Qty: 103 Price: ₹98.55 Buy EPS: ₹16.5

Sell date: 03-Oct-2022

Qty:103  Price: ₹101.4 Buy Eps: ₹16.5

Profit: 293.55

***

Buy date: 30-Sep-2022

Qty: 103 Price: ₹98.37 Buy EPS: ₹16.5

Sell date: 30-Sep-2022

Qty:103  Price: ₹101 Buy Eps: ₹16.5

Profit: 270.89

***

Buy date: 23-Aug-2022

Qty: 102 Buy Price: 97.6 Buy EPS: ₹16.5

Sold Date: 24-Aug-2022

Qty: 102 Sold Price: 100.1 Sold EPS: ₹16.5

Profit: 245.82

***

Buy date: 24-Aug-2022

Qty: 101 Buy Price: 99 Buy EPS: ₹16.5

Sold Date: 24-Aug-2022

Qty: 101 Sold Price: 100 Sold EPS: ₹16.5

Profit: 101

***

Will sell if the stock is out of HDY screen even if it is at a loss.

1 Manali Petrochemicals Update

Reasons for buying:

Buy PE was reasonable at 4.19 and below 10 years PE median of 6.75.

The 5-year earnings average is 33.22% but lackluster for years.

Return on equity is good at 34.66% but the 5-year average is 18.34%.

The market cap of the company is ₹1,670.11 Cr.

The debt of the company is 14.28 Cr with ₹286.96 Cr in cash.

Buy date: 02-Mar-2022

Qty: 103 Buy Price: 96.55 Buy EPS: 23.16 Buy PE: 4.19

I will stop buying when EPS drops to 4.8275

Stock is yielding 3% at 83.1 and will hold forever max risk is 1lakh if the stock goes to zero.

Buy date: 12-Dec-2022

Qty: 1098 Buy Price: 83.1 Buy EPS: 13.49

Manali Petrochemicals Ltd operates in the chemical industry. The company is engaged in the manufacture and sale of Propylene Oxide (PO), Propylene Glycol (PG), and Polyols (PY). It serves various industries such as appliances, automotive, bedding, food and fragrances, furniture, footwear, paints and coating, and pharmaceuticals. The company's only operating segment includes the manufacture and sale of petrochemical products. Geographically, it operates only in India.

Sunday 11 December 2022

FDC Update

Buy date: 04-Jan-2022

Qty: 32 Price: 305.65 EPS: 17.26

Buyback date: 06-May-2022

Qty: 4 Price: 475

Sell date: 12-Dec-2022

Qty:28 Price: 285 EPS: 10.06

Profit: 99

Holding Period: 342 days

It has some cash and thought earnings would improve but they didn't hence selling close to 30 PE. When placing AMO sold at market price instead of PE 30 price since its close to 30 PE did not buy back.

Thursday 8 December 2022

Investment Policy Statement

Got this idea from the below link and it raised many questions
http://somerandomguyonline.com/helicopter-investor/

Create an investment policy statement

An investment policy statement (IPS) is a statement or document that outlines your general investment goals and objectives. It also establishes your specific investment strategy, risk tolerance, asset allocation, and investment philosophy. You can also include a section on how often you want to monitor your portfolio and when to rebalance it. Write your IPS down. Keep it handy so you can refer to it when needed.

Investment Policy Statement

I already have one but not as specific as it should be.

Original: To have 25 times my last 12 months' expenses and not touch the savings at any cost unless medical emergency or job loss.

My investment strategy is simple, to put money in dynamic PE FOF after-tax investing.

Risk tolerance is low so invested in a dynamic fund that invests in both debt and equity.

Asset Allocation is simple too as the fund does it every month based on the PE ratio.

The investment philosophy is to take less risk and ride the equity and debt markets at the same time and long enough to reach my goal to have 25 times my last 12 months' expenses (I should be tracking my expenses every month without fail).

21-07-18:

New statement:

Original ambition remains the same but changes in asset allocation. PE fund is charging me 1.5% and if I am FI a few years from now and plan to withdraw 4% the expenses alone will consume 37.5% of my withdrawal. This is a high-cost option, I think I am making excuses for not planning to work and being lazy and planning to retire in 5 years, but caring for my mother the financial burden makes me think I should work as long as I can and build wealth for myself and my kid.

My investment strategy is simple, to put money in Nifty 100 index funds after-tax investing.

Risk tolerance is high as I am planning to be in the workforce as long as I can, even if disasters occur I plan to cover expenses through the emergency funds, PF money which I can withdraw in case of job loss or medical emergency. 

Asset Allocation is simple too as funds invest in Nifty 100 at a low cost. I am not planning to re-balance as I am in the wealth accumulation phase, will think once I am FI on allocation change.


An investment philosophy is to take high risks and ride the equity markets and use emergency and PF cash in case of tough times and long enough to reach my goal to have 25 times my last 12 months' expenses (I should be tracking my expenses every month without fail).

How often do you want to monitor your portfolio?

I am monitoring it daily now, which is not a good thing but can not help it. I Will see if I can monitor it only on weekends.

Stick with YOUR plan
Have to see how long I am going to stick to the plan.
(Aug17,Sep17,Oct17,Nov17,Dec17,Jan17,Feb17,Mar17,Apr17,May17,June17,July17) lasted for a year.

A new plan from August 18:

Invest in index funds UTI Nifty Index Fund and UTI Nifty Next 50 Index Fund hoping to invest for 10 years at least. The change in plan is to use a low-cost option and ride the tide with an emergency and PF cash cushion.

If money is in the Index I should monitor it once every month to calculate net worth.

A new plan from 5th May 21:

Invest in morningstar managed portfolio, ELSS/NPS Tier I for tax purposes, and invest in direct equities. The idea is to never sell any stocks or mutual funds I buy from here on. The coffee can portfolio will be a cornerstone for my investments from now on. The idea is that we have to give time for investments to mature for at least 10 years and choose carefully. It is tough to find stocks that give a CAGR return of 10% annually so if I buy something which gives that kind of return it makes sense to keep it rather than churn.

I will sell my investments only when I need money for emergencies (medical/unexpected travel) or unexpected events(job loss).

I will sell my investments when I need money to provide for my kid's education.

I will sell my investment if my investment thesis is wrong or if the investment turned out to be a fraud.

I will sell my investment if the CAGR for 10 years is less than the SBI home loan rate.

A new plan from 29th Nov 21:

Stay invested in morningstar managed portfolio, NPS Tier I for tax purposes, and invest in direct equities. Manas education fund will come from Morningstar's managed portfolio. Short-term goals will be done via ICICI I Wish goals.

I am selling direct stocks when PE is 30 for earnings strategy added HDY and AB strategy. AB will be a long-term core portfolio where the stocks are held for the very long term.

Unfortunately, I have used my emergency fund to buy stocks and am in process of building.

I will sell stocks based on set rules.

I will maintain emergency funds for 1 year of expenses in a high savings account.

I will not touch direct mutual funds.

I will sell investments only when I need money for emergencies (medical/unexpected travel) or unexpected events(job loss).

I will sell investments when I need money to provide for my kid's education.

I will sell an investment if the investment thesis is wrong or the investment turned out to be a fraud.

Step 1: Have the last 12 months' expenses as an emergency fund.

Step 2: Fund Manas education fund and other short-term goals.

Step 3: Fund tax-advantaged investment.

Step 4: Invest in direct equities.

Step 5: The idle money will be in a savings account.


May 22:

Step 1: Have the last 12 months' expenses as an emergency fund.

Step 2: Fund Manas education fund and other short-term goals.

Step 3: Fund NPS 50,000.

Step 4: Invest in direct equities and a small portion in Index funds.

Step 5: The idle money will be in a savings account or T-Bills.


Dec 9:

I am planning to buy dividend stocks only going forward, planning to invest 1 lakh in each stock with a 3% dividend yield, and hope the stock continues to pay a dividend. This allows me to deploy capital faster and the cost will be minimal. I have to deploy capital and let the company perform. Profits will only be dividends and no capital gains. I am also letting the company compound the retained earnings while using dividends if needed or buying more dividend companies. I will be the owner of the company if I do not sell. The disadvantage is missing in growth companies and attractive blue chip companies. I will miss a cash cushion. The stock market can fall 50% and I have to brace up for the ride. If the stock doesn't pay dividends it will not help me. 

Tuesday 6 December 2022

9 Rashtriya Chemicals and Fertilizers Update

The stock came up on the HDY screen and I will hold it for longer and hope the company pays dividends.

***

Buy date: 23-Dec-2022

Qty: 871 Price: ₹113.25 EPS₹17.01


 The stock came up on the HDY screen and will hopefully sell in a short period of time.

***

Buy date: 02-Dec-2022

Qty: 80 Price: ₹123.65 EPS₹17.01

Sell date: 07-Dec-2022

Qty: 80 Price: 128.6 EPS: ₹17.01

Profit: 396

***

Will sell if it is not present on the screen

SMC Global Securities Update

The stock came up on the HDY screen and will hopefully sell in a short period of time.

***

Buy date: 16-Nov-2022

Qty: 126 Price: ₹79 EPS₹15.59

Sell date: 06-Dec-2022

Qty: 126 Price: ₹80.8 EPS₹15.59

Profit: 226.8

***

Will sell if it is not present on the screen

Monday 5 December 2022

NMDC Update

Reasons for buying:

Buy PE was reasonable at 4.56 and below 10 years PE median of 9.01.

Earnings have increased since 2017 but earnings went nowhere from 2012.

Return on equity is good at 21.81%.

The market cap of the company is ₹41,907.66cr.

The debt of the company is 1,994.47cr with ₹5,861.82cr in cash.

Buy date: 25-Oct-2021

Qty: 71 Buy Price: ₹139 Buy EPS: 30.48 Buy PE: 4.56

New demerger price: 59.37

Buy date: 07-Jun-2022

Qty: 80 Buy Price: ₹124 Buy EPS: 32 Buy PE: 3.875

New demerger price: 52.96

Buy date: 07-Jul-2022

Qty: 93 Buy Price: ₹139 Buy EPS: 32 Buy PE: 3.35

New demerger price: 45.91

Name of Company Percentage of Cost of Acquisition of equity shares in Demerged and Resulting Company NMDC Limited 42.71% (Demerged Company) NMDC Steel limited 57.29% (Resulting Company) Total 100.00% 

The price of the stock is up about 2.88% from my buy price.

The company is involved in the exploration of iron ore, copper, rock phosphate, limestone, dolomite, gypsum, bentonite, magnesite, diamond, tin, tungsten, graphite, etc.

Aarti Industries Update

Reasons for buying:

Market Cap: ₹28,306 Cr (Bluechip stock)

Debt to Equity: 0.16

Return on Equity 5Y Avg: 22.26%

EPS - 5Y Growth: 30.27%

Price-earnings to growth (5Y): less than 1.5

5Y RoE Consistency - Sustained without losing 20% in any year

***

Buy date: 9-Sep-2022

Qty: 11 Buy Price: ₹854.85 Buy EPS: 36.73

New Price after demerger: 646.10

***

Buy date: 29-Sep-2022

Qty: 13 Buy Price: ₹769 Buy EPS: 36.73

New Price after demerger: 581.21

Will continue to add when a stock falls 10% as long as the ratios remain the same. The stock would take a long time to pay, it lost 10% in 20 days.

***

Buy date: 20-Oct-2022

Qty: 14 Price: ₹683 EPS: 36.73

***

Due to the demerger, the cost of the acquisition of my shares changed.

Sr. No. Name of the Company Percentage of cost of acquisition of equity shares

1 Aarti Pharmalabs Limited (Resulting Comoanvl 24.42%

2 Aarti Industries Limited (Dernerged Cornoanvl 75.58%

Total 100.00% 

Aarti Industries manufactures and sells chemicals and chemical-based products in two segments based on the product type. The specialty chemical segment which generates the majority of revenue sells benzene-based chemicals which are used in agricultural products dyes and pigments and flavors and fragrances. The pharmaceuticals segment sells drugs used to treat diarrhea, inflammation, and asthma as well as antibiotics and antidiabetics. More revenue comes from India than any other country or region.

Wednesday 30 November 2022

Maharashtra Scooters

This is part of book value investing

PB<.5

Book value growth 10Y and 5Y more than 10%.

Book Value: 20309

Buy date: 30-Nov-2022

Qty: 2 Price: 4974.75 EPS: ₹171.8 PB: 0.26

I will sell at book value and plan to update the GTT order in Zerodha every week by checking Tradeview. If the book value decreases I will lose money otherwise hoping the company can increase book value and sell it at book value a few years from now. Usually, book value investing takes at least 5 years and in some cases can hit PB =1 once in 10 years. In this case, it may not hit PB=1 and hope to collect dividends. I will not average this stock if earnings fall.

Tuesday 29 November 2022

Ishan Dyes & Chemicals Update

Reasons for buying:

Buy PE was reasonable at 10.57 and above 10 years PE median of 8.56.

Earnings have increased 3 times since 2012.

Return on equity is ok at 21.45%.

The market cap of the company is ₹159.20cr.

The debt of the company is ₹2.41cr with ₹1.16cr in cash.

Buy date: 21-Sep-2021 

Qty: 106 Buy Price: ₹94.02 Buy EPS:  8.89 Buy PE: 10.57

The price of the stock is up about 5.86% from my buy price.

Sold Date: 29-Nov-2021 

Qty: 106 Price: ₹66.9 Buy EPS:  2.23 PE: 30

I have lost -2874 on this after holding for 434 days.

The company manufactures chemicals. A very low market cap company but I am hoping earnings will improve.

Wednesday 23 November 2022

Rail Vikas Nigam Update

The stock came up on the HDY screen. These trades are short-term.

***

Buy date: 22-Nov-2022

Qty: 166 Price: ₹60 Buy EPS: ₹6.48

Sell date: 23-Nov-2022

Qty:166 Price: ₹61.7 Buy Eps: ₹6.48

Profit: ₹282.2

***

Buy date: 24-Aug-2022

Qty: 325 Price: ₹30.7 Buy EPS: ₹5.99

Sell date: 17-Nov-2022

Qty:325  Price: ₹63.75 Buy Eps: ₹6.48

Profit: 10,822.5 including 81.25 dividend

***

Will sell if the stock is out of HDY screen even if it is at a loss.

Tuesday 22 November 2022

Kwality Pharmaceuticals

Reasons for buying:

Buy PE was reasonable at 7.9 and the 10-year median PE is 22.

The 5-year earnings average is 104% and earnings increasing since 2014.

Return on equity is good at 99.05% but the 5-year average is 37.25%.

The market cap of the company is ₹3,560 Cr.

The debt of the company is 54.01 Cr with ₹12.95 Cr cash.

Buy date: 23-N0v-2022

Qty: 29 Buy Price: 343.5 Buy EPS: ₹43.46 Buy PE: 7.9

Will add to stock only if earnings rise and price drops.

Kwality Pharmaceuticals is an India-based pharmaceutical company. it is principally engaged in manufacturing finished pharmaceutical formulations in a dosage form. The company manufactures and exports pharmaceutical formulations in liquid orals, dry syrups, tablets, capsules, sterile powder for injections, and small-volume injectables. It also manufactures veterinary pharmaceutical products.

Sunday 20 November 2022

Polyplex Corp Update

I may have purchased at high PE of 12.75 considering the 10-year PE median is 6.75.

Buy Date: 28-Jun-2022

Qty: 4    Price: 2,311    EPS: 181.79    PE: 12.75

The reason for adding is EPS has increased from 181.19 to 211.29

Buy Date: 21-Nov-2022
Qty:5    Price: 1,845.9    EPS: 211.29    PE: 8.73

ROE is 18.87 and 5-year ROE is 12.66
Debt/Equity is 0.25
5-year EPS growth is 21.22

Polyplex Corp is an India-based company engaged in the manufacturing of plastic films. The company diversified its business under Polyethylene Terephthalate films. Cast Polypropylene films, and Biaxially Oriented Polypropylene. These products act as raw materials for their product applications like packaging, industrial, and specialties, electrical, roofing, and others. Geographically, it derives a majority of its revenue from Outside India.

Friday 18 November 2022

Mangalam Organics Update

Reason for buying:



PE is reasonable and with more than 10 years PE median of 5.52.

Earnings have increased although unevenly in the last 5 years.

Operating margins have improved in the last 3 years.

Return on equity has improved in the last 3 years.

Debt is low at 20 cr and cash is 0.69 cr.

The threat of the company’s solvency is less; Altman Z-Score is 12.52

The market cap of the company is 648 cr.

 

Buy date: 05/14/2021

Buy Price: 704         Qty: 14         Buy EPS: 75.08        Buy PE: 9.37


27th May 2021:

Q4 results: Current EPS is 99.21 and increased by 32.14% from my buy EPS.


Buy date: 07/13/2022

Price: 600.75    Qty: 16    EPS: 62.75    PE: 9.57


Sell date: 11/18/2022

Price: 534.75    Qty: 30    EPS: -13.84    PE is negative


It is making losses for the last 2 quarters so sold it. I lost 3,359.5 in this stock.


Disclaimer: The video is for educational purposes for my family and friends. I am not a financial advisor and do not consider it as buy or sell. Taking advice from a random guy on the internet is harmful to your portfolio. I do not do a deep analysis of stocks I buy them just as a hobby.